NoIR 25% Medium Amber Fitover Medium
by NoIR
Last verified June 19, 2026 · classified April 26, 2026
What it is
Summary
AI-generated from vendor-published content · April 26, 2026
These are fitover tinted lenses with a medium amber filter that blocks glare, UV, infrared, and high-energy blue light — designed to be worn directly over most prescription eyeglasses. They're intended for people with light-sensitive vision conditions such as macular degeneration, glaucoma, cataracts, retinitis pigmentosa, or diabetic retinopathy, where unfiltered light causes discomfort or further visual difficulty. This is a complete, ready-to-wear product: no setup required, and the wraparound frame with side shields helps block light from the edges as well as the front. The 25% amber designation in the product name conflicts with the 15% light transmission figure in the description — confirm the exact tint level with the vendor before purchasing if the precise transmission percentage matters for your condition.
Quick Facts Catalog facts · auto-generated
- AT Act lending
- Out of pocket
What Setup Looks Like
- Out of the box
- Slide the fitover frame over your existing prescription glasses or wear alone.
- Adjust the curved temple pieces for a secure, non-slip fit.
Getting it
Try Before You Buy
Devices like this are often available to borrow through your state's AT Act program — typically free or low-cost — so you can try it before buying or pursuing funding.
Where to Get It
Some links may be affiliate links — WhatCanHelp may earn a small commission from purchases at no extra cost to you. More on affiliates →
As an Amazon Associate we earn from qualifying purchases.
Wondering how equipment like this gets paid for? See the official funding programs in your state.
Compare & explore
Sources & fine print
Vendor facts (name, price, platforms, vendor link) sourced from NoIR — view on vendor site; last verified June 19, 2026.
Classification & description AI-generated from vendor-published content on April 26, 2026 · confidence: high. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.